KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $215.0 million.

  • Medtronic's Tax Provisions fell 2348.75% to $215.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $906.0 million, marking a year-over-year increase of 876.35%. This contributed to the annual value of $936.0 million for FY2025, which is 1738.75% down from last year.
  • Per Medtronic's latest filing, its Tax Provisions stood at $215.0 million for Q4 2025, which was down 2348.75% from $255.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Tax Provisions ranged from a high of $959.0 million in Q4 2022 and a low of -$59.0 million during Q1 2021
  • In the last 5 years, Medtronic's Tax Provisions had a median value of $199.5 million in 2021 and averaged $235.8 million.
  • In the last 5 years, Medtronic's Tax Provisions skyrocketed by 46774.19% in 2021 and then crashed by 5808.13% in 2023.
  • Medtronic's Tax Provisions (Quarter) stood at $176.0 million in 2021, then skyrocketed by 444.89% to $959.0 million in 2022, then plummeted by 58.08% to $402.0 million in 2023, then plummeted by 30.1% to $281.0 million in 2024, then decreased by 23.49% to $215.0 million in 2025.
  • Its last three reported values are $215.0 million in Q4 2025, $255.0 million for Q3 2025, and $199.0 million during Q2 2025.